Announced Tue, 26 May · 20:33 IST

Standalone Audited Financial Results for the quarter and year ended March 31, 2026.

Pat Growth 25pctDebt Equity ThresholdResults View source PDF

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.7%1-day move
₹110.85
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-2.6-1.2+1.0-0.8+5.6+20.2+9.6+7.2
Up moveDown movePending
AI summary

Lotus Eye Hospital reported strong financial performance for FY2026 with total income of Rs. 5,489.03 lakhs, up 7.9% from Rs. 5,086.38 lakhs in FY2025. Revenue from operations grew 8.4% to Rs. 5,371.41 lakhs. Net profit surged significantly to Rs. 73.93 lakhs from Rs. 25.23 lakhs in the previous year, driven by improved operational efficiency. For Q4 FY2026 alone, revenue was Rs. 1,360.92 lakhs with net profit of Rs. 27.99 lakhs. The statutory auditor issued an unmodified (clean) opinion confirming true and fair view of financial statements. The company spent heavily on capital expenditure (Rs. 1,294.91 lakhs on PPE) during the year, funded partly through increased long-term borrowings.

Likely market impact

Positive signal for shareholders as net profit nearly tripled year-on-year, indicating improved profitability and operational efficiency. The clean audit opinion removes any concerns about financial reporting quality.